WELL Research And Ddevelopement To Revenue from 2010 to 2024
| WELL Stock | CAD 6.79 0.09 1.31% |
Research And Ddevelopement To Revenue | First Reported 2010-12-31 | Previous Quarter 0.00445974 | Current Value 0.005498 | Quarterly Volatility 0.00027748 |
Check WELL Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WELL Health's main balance sheet or income statement drivers, such as Interest Expense of 32.9 M, Selling General Administrative of 223.3 M or Other Operating Expenses of 771.7 M, as well as many indicators such as Price To Sales Ratio of 1.11, Dividend Yield of 0.0 or PTB Ratio of 1.23. WELL financial statements analysis is a perfect complement when working with WELL Health Valuation or Volatility modules.
WELL | Research And Ddevelopement To Revenue |
Other Information on Investing in WELL Stock
WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.